- Report
- October 2024
- 190 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- January 2025
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2025
- 277 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- September 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- July 2024
- 100 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- April 2023
- 87 Pages
Global
From €3500EUR$3,929USD£3,035GBP
The Balloon Valvuloplasty Device market is a segment of the Medical Devices industry that focuses on the development and production of devices used to treat valvular heart disease. These devices are used to open narrowed or blocked heart valves, allowing for improved blood flow. The procedure is minimally invasive and can be performed in a hospital or clinic setting.
The Balloon Valvuloplasty Device market is driven by the increasing prevalence of valvular heart disease, as well as the growing demand for minimally invasive treatments. Technological advancements in the field have also contributed to the growth of the market.
Some of the major players in the Balloon Valvuloplasty Device market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, and B. Braun Melsungen AG. Show Less Read more